{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Implants expérimentaux : Questions médicales les plus fréquentes",
"headline": "Implants expérimentaux : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Implants expérimentaux : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-19",
"dateModified": "2025-05-14",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Implants expérimentaux"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Prothèses et implants",
"url": "https://questionsmedicales.fr/mesh/D019736",
"about": {
"@type": "MedicalCondition",
"name": "Prothèses et implants",
"code": {
"@type": "MedicalCode",
"code": "D019736",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E07.695"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Implants expérimentaux",
"alternateName": "Implants, Experimental",
"code": {
"@type": "MedicalCode",
"code": "D020007",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Javier Sanz-Esporrin",
"url": "https://questionsmedicales.fr/author/Javier%20Sanz-Esporrin",
"affiliation": {
"@type": "Organization",
"name": "ETEP (Etiology and Therapy of Periodontal and Peri-Implant Diseases) Research Group, Faculty of Odontology, Universidad Complutense de Madrid, 28040, Madrid, Spain. javisanzes@gmail.com."
}
},
{
"@type": "Person",
"name": "Mariano Sanz",
"url": "https://questionsmedicales.fr/author/Mariano%20Sanz",
"affiliation": {
"@type": "Organization",
"name": "ETEP (Etiology and Therapy of Periodontal and Peri-Implant Diseases) Research Group, Faculty of Odontology, Universidad Complutense de Madrid, 28040, Madrid, Spain."
}
},
{
"@type": "Person",
"name": "Juan Blanco",
"url": "https://questionsmedicales.fr/author/Juan%20Blanco",
"affiliation": {
"@type": "Organization",
"name": "Periodontology Unit, School of Medicine and Dentistry, University of Santiago de Compostela, Santiago de Compostela, Spain."
}
},
{
"@type": "Person",
"name": "Fernando Muñoz",
"url": "https://questionsmedicales.fr/author/Fernando%20Mu%C3%B1oz",
"affiliation": {
"@type": "Organization",
"name": "IboneLab. Department of Veterinary Clinical Sciences, University of Santiago de Compostela, Lugo, Spain."
}
},
{
"@type": "Person",
"name": "Renata Falchete do Prado",
"url": "https://questionsmedicales.fr/author/Renata%20Falchete%20do%20Prado",
"affiliation": {
"@type": "Organization",
"name": "Department of Bioscience and Oral Diagnosis, Institute of Science and Technology, UNESP-São Paulo State University São José dos Campos, São Paulo 12245-000, Brazil."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Programmed cell death-1 blockade therapy in melanoma: Resistance mechanisms and combination strategies.",
"datePublished": "2023-01-24",
"url": "https://questionsmedicales.fr/article/36645031",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/exd.14750"
}
},
{
"@type": "ScholarlyArticle",
"name": "MicroRNAs Targeting Programmed Cell Death Protein 1 (PD-1) Promote Natural Killer Cell Exhaustion in Rheumatoid Arthritis.",
"datePublished": "2022-12-24",
"url": "https://questionsmedicales.fr/article/36640056",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.18502/ijaai.v21i6.11524"
}
},
{
"@type": "ScholarlyArticle",
"name": "Differential expression of programmed death 1 (PD-1) on various immune cells and its role in human leprosy.",
"datePublished": "2023-04-21",
"url": "https://questionsmedicales.fr/article/37153623",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fimmu.2023.1138145"
}
},
{
"@type": "ScholarlyArticle",
"name": "A High Programmed Cell Death Protein 1 Hormone Receptor Score on Skin Biopsy is Associated with Sézary Syndrome Diagnosis: A Study of 91 Patients with Erythroderma.",
"datePublished": "2022-09-06",
"url": "https://questionsmedicales.fr/article/35758515",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2340/actadv.v102.1062"
}
},
{
"@type": "ScholarlyArticle",
"name": "Functionalized biomimetic nanoparticles combining programmed death-1/programmed death-ligand 1 blockade with photothermal ablation for enhanced colorectal cancer immunotherapy.",
"datePublished": "2022-11-25",
"url": "https://questionsmedicales.fr/article/36442821",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.actbio.2022.11.043"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Équipement et fournitures",
"item": "https://questionsmedicales.fr/mesh/D004864"
},
{
"@type": "ListItem",
"position": 3,
"name": "Prothèses et implants",
"item": "https://questionsmedicales.fr/mesh/D019736"
},
{
"@type": "ListItem",
"position": 4,
"name": "Implants expérimentaux",
"item": "https://questionsmedicales.fr/mesh/D020007"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Implants expérimentaux - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Implants expérimentaux",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-18",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Implants expérimentaux",
"description": "Comment évaluer l'efficacité d'un implant expérimental ?\nQuels tests sont utilisés pour surveiller les implants ?\nComment détecter une infection liée à un implant ?\nQuels signes indiquent un rejet d'implant ?\nComment évaluer la biocompatibilité d'un implant ?",
"url": "https://questionsmedicales.fr/mesh/D020007?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Implants expérimentaux",
"description": "Quels symptômes peuvent survenir après la pose d'un implant ?\nComment reconnaître une réaction allergique à un implant ?\nQuels symptômes indiquent une défaillance de l'implant ?\nQuels signes d'infection doivent alerter ?\nQuels symptômes peuvent indiquer une complication tardive ?",
"url": "https://questionsmedicales.fr/mesh/D020007?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Implants expérimentaux",
"description": "Comment prévenir les infections après un implant ?\nQuelles précautions prendre avant une chirurgie d'implant ?\nComment réduire le risque de rejet d'implant ?\nQuels conseils pour le suivi post-implantation ?\nComment éviter les complications liées aux implants ?",
"url": "https://questionsmedicales.fr/mesh/D020007?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Implants expérimentaux",
"description": "Quels traitements sont disponibles pour les complications d'implants ?\nComment gérer la douleur post-implantation ?\nQuelles sont les options si un implant échoue ?\nComment traiter une infection liée à un implant ?\nQuels soins post-opératoires sont nécessaires ?",
"url": "https://questionsmedicales.fr/mesh/D020007?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Implants expérimentaux",
"description": "Quelles sont les complications possibles des implants ?\nComment gérer une infection post-implantation ?\nQuels sont les signes d'une défaillance d'implant ?\nQuelles sont les conséquences d'une réaction allergique ?\nComment prévenir les complications liées aux implants ?",
"url": "https://questionsmedicales.fr/mesh/D020007?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Implants expérimentaux",
"description": "Quels facteurs augmentent le risque d'infection ?\nComment l'âge influence-t-il le risque d'échec d'implant ?\nQuels médicaments peuvent affecter la cicatrisation ?\nComment le mode de vie influence-t-il le succès des implants ?\nQuels antécédents médicaux augmentent les risques ?",
"url": "https://questionsmedicales.fr/mesh/D020007?mesh_terms=Programmed+Cell+Death+1+Receptor&page=3#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment évaluer l'efficacité d'un implant expérimental ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'efficacité est évaluée par des études cliniques contrôlées et des essais randomisés."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour surveiller les implants ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des imageries médicales et des tests fonctionnels sont utilisés pour surveiller les implants."
}
},
{
"@type": "Question",
"name": "Comment détecter une infection liée à un implant ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses sanguines et des cultures de tissus peuvent aider à détecter une infection."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent un rejet d'implant ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Rougeur, douleur, gonflement et fièvre peuvent indiquer un rejet d'implant."
}
},
{
"@type": "Question",
"name": "Comment évaluer la biocompatibilité d'un implant ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests in vitro et in vivo sont réalisés pour évaluer la biocompatibilité."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent survenir après la pose d'un implant ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Douleur, gonflement et rougeur au site d'implantation sont fréquents."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une réaction allergique à un implant ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des démangeaisons, éruptions cutanées ou œdème peuvent signaler une allergie."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une défaillance de l'implant ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Instabilité, douleur persistante ou mobilité anormale de l'implant peuvent indiquer une défaillance."
}
},
{
"@type": "Question",
"name": "Quels signes d'infection doivent alerter ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, écoulement purulent et douleur intense au site d'implant doivent alerter."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une complication tardive ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs chroniques ou des changements de fonction peuvent indiquer des complications tardives."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections après un implant ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène et suivre les recommandations médicales aide à prévenir les infections."
}
},
{
"@type": "Question",
"name": "Quelles précautions prendre avant une chirurgie d'implant ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Informer le médecin des allergies et des médicaments en cours est crucial avant la chirurgie."
}
},
{
"@type": "Question",
"name": "Comment réduire le risque de rejet d'implant ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le choix d'un implant biocompatible et un suivi médical régulier peuvent réduire le risque de rejet."
}
},
{
"@type": "Question",
"name": "Quels conseils pour le suivi post-implantation ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Respecter les rendez-vous de suivi et signaler tout symptôme anormal au médecin."
}
},
{
"@type": "Question",
"name": "Comment éviter les complications liées aux implants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Choisir un professionnel qualifié et respecter les consignes pré et post-opératoires aide à éviter les complications."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les complications d'implants ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des antibiotiques, des interventions chirurgicales ou le retrait de l'implant."
}
},
{
"@type": "Question",
"name": "Comment gérer la douleur post-implantation ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analgésiques et des anti-inflammatoires peuvent être prescrits pour gérer la douleur."
}
},
{
"@type": "Question",
"name": "Quelles sont les options si un implant échoue ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les options incluent le retrait de l'implant, la réparation ou le remplacement par un nouveau dispositif."
}
},
{
"@type": "Question",
"name": "Comment traiter une infection liée à un implant ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement implique généralement des antibiotiques et parfois un drainage chirurgical."
}
},
{
"@type": "Question",
"name": "Quels soins post-opératoires sont nécessaires ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des soins réguliers du site d'implant et des suivis médicaux sont essentiels."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles des implants ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent infections, défaillances mécaniques et réactions allergiques."
}
},
{
"@type": "Question",
"name": "Comment gérer une infection post-implantation ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement antibiotique et, si nécessaire, un drainage chirurgical sont souvent requis."
}
},
{
"@type": "Question",
"name": "Quels sont les signes d'une défaillance d'implant ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Instabilité, douleur accrue et mobilité anormale sont des signes de défaillance."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une réaction allergique ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les réactions allergiques peuvent entraîner des démangeaisons, des éruptions cutanées et un inconfort."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications liées aux implants ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un suivi régulier et une bonne hygiène sont essentiels pour prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'infection ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diabète, l'obésité et le tabagisme augmentent le risque d'infection post-implantation."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il le risque d'échec d'implant ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées peuvent avoir un risque accru d'échec d'implant en raison de la diminution de la cicatrisation."
}
},
{
"@type": "Question",
"name": "Quels médicaments peuvent affecter la cicatrisation ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les anticoagulants et les immunosuppresseurs peuvent retarder la cicatrisation après une chirurgie d'implant."
}
},
{
"@type": "Question",
"name": "Comment le mode de vie influence-t-il le succès des implants ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un mode de vie sain, sans tabac et avec une alimentation équilibrée, favorise le succès des implants."
}
},
{
"@type": "Question",
"name": "Quels antécédents médicaux augmentent les risques ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des antécédents de maladies auto-immunes ou d'infections chroniques peuvent augmenter les risques."
}
}
]
}
]
}
Melanoma is a highly aggressive tumor derived from melanocytes. In recent years, the incidence and mortality of melanoma have gradually increased, seriously threatening human health. Classic treatment...
Natural killer (NK) cells play a role in the pathogenesis of rheumatoid arthritis (RA). Upregulated levels of programmed cell death protein 1 (PD-1) is a sign of exhausted NK cells that could be regul...
Erythroderma is challenging to diagnose. The aim of this single-centre retrospective study was to identify factors that can be used to improve the diagnosis of erythroderma. Among 91 patients with ery...
Immune checkpoint blockade therapy targeting programmed death-1 (PD-1) or its major ligand programmed death-ligand 1 (PD-L1) has achieved remarkable success in the treatment of several tumors, includi...
The immune system uses various immune checkpoint axes to adjust responses, support homeostasis, and deter self-reactivity and autoimmunity. Nevertheless, non-small-cell lung carcinoma (NSCLC) can use ...
Pembrolizumab or nivolumab plus chemotherapy was approved as a first-line treatment for high programmed cell death ligand 1 (PD-L1)-expressing esophageal squamous cell carcinoma (ESCC) by the European...
Post hoc analysis of the Chinese JUPITER-06 study focusing on efficacy stratified by PD-L1 tumor proportion score (TPS; using JS311 antibody) was conducted. Electronic databases were searched to ident...
The post hoc analysis of JUPITER-06 showed more prominent clinical benefit with PD-1 antibody plus chemotherapy than with chemotherapy alone in both the high and low PD-L1-expressing subgroups. Five r...
This study provided novel evidence supporting the superiority of PD-1 antibody plus chemotherapy to chemotherapy alone in patients with advanced ESCC with low PD-L1 expression. Further studies of pred...
Major depression (MD) may be associated with inflammation and immunity. PD-1 (programmed death-1), PD-L1 (programmed death-ligand 1) and PD-L2 (programmed death-ligand 2) are among the inhibitory immu...
During a period of 2 years, patients with MD and healthy controls were recruited from a medical centre in this study. The diagnosis of MD was established according to the DSM-5 criteria. The severity ...
A total of 54 patients with MD and 38 healthy controls were recruited. According to the analyses, there is a significantly higher PD-L2 level in MD than in healthy controls and lower PD-1 level after ...
It was found that PD-1 pathway might play an important role in MD. We need a large sample to prove these results in the future....
Tumor-infiltrating lymphocytes are detectable in up to 75% of triple-negative breast cancer. The composition of these infiltrates may influence prognosis and is not known regarding regulatory or effec...
This was a retrospective observational study. Clinical and pathological data from 38 triple-negative breast cancer patients treated with neoadjuvant chemotherapy at the University Hospital (HUCFF/UFRJ...
Statistically significant changes in stromal tumor-infiltrating lymphocyte categories were observed before and post-neoadjuvant chemotherapy, with 32% of intermediate cases becoming high. The correlat...
In this study, we observed that chemotherapy significantly increases stromal tumor-infiltrating lymphocytes, CD8 T cells, as well as CD8/FoxP3 ratio. Most importantly, programmed cell death protein 1 ...
Melanoma is widely treated with programmed cell death-1 (PD-1) inhibitors. As part of their anti-tumor immunity effect, they increase the susceptibility to cutaneous immune-related adverse events (cIR...